Rabitec

Țară: Uniunea Europeană

Limbă: engleză

Sursă: EMA (European Medicines Agency)

Cumpara asta acum

Prospect Prospect (PIL)
07-01-2021

Ingredient activ:

attenuated live rabies vaccine virus, strain SPBN GASGAS

Disponibil de la:

CEVA Santé Animale

Codul ATC:

QI07BD

INN (nume internaţional):

Rabies vaccine (live, oral) for foxes and raccoon dogs

Grupul Terapeutică:

Red foxes (Vulpes vulpes); Raccoon dogs (Nyctereutes procyonoides)

Zonă Terapeutică:

Immunologicals for canidae, Live viral vaccines

Indicații terapeutice:

For the active immunisation of foxes and raccoon dogs against rabies to prevent infection and mortality.

Rezumat produs:

Revision: 3

Statutul autorizaţiei:

Authorised

Data de autorizare:

2017-12-01

Prospect

                                B. PACKAGE LEAFLET
15
PACKAGE LEAFLET
RABITEC ORAL SUSPENSION, FOR FOXES AND RACCOON DOGS
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE, IF DIFFERENT
Marketing authorisation holder:
Ceva Santé Animale
10 av. de La Ballastière
33500 Libourne
France
Manufacturer responsible for batch release:
IDT Biologika GmbH
Am Pharmapark
06861 Dessau-Rosslau
Germany
Ceva Tiergesundheit (Riems) GmbH
An der Wiek 7
17493 Greifswald - Insel Riems
Germany
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Rabitec oral suspension for foxes and raccoon dogs
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
1 dose (1.7 ml) embedded in bait contains:
ACTIVE SUBSTANCE:
Attenuated live rabies vaccine virus, strain SPBN GASGAS:
10
6.8
FFU* - 10
8.1
FFU*
(* Focus Forming Units)
The suspension has a yellow colour in a frozen state and a reddish
colour in the liquid state. The baits
are rectangular, brown coloured and have an intensive smell.
4.
INDICATION(S)
For the active immunization of foxes and raccoon dogs against rabies
to prevent infection and
mortality.
Duration of immunity: at least 12 months.
5.
CONTRAINDICATIONS
None.
16
6.
ADVERSE REACTIONS
Not known.
If you notice any side effects, even those not listed in this package
leaflet or you think that the
medicine has not worked, please inform your veterinary surgeon.
7.
TARGET SPECIES
Foxes, raccoon dogs
8.
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
Oral use.
The intake of single bait is sufficient to ensure active immunisation
to prevent infection by rabies
virus. The baits are distributed by land or by air within the
framework of vaccination campaigns
against rabies.
The vaccination area should be as large as possible (preferably larger
than 5,000 km
2
). The vaccination
campaigns in rabies-free areas should be designed in such a way that
the area covers a 50 km belt
ahead of the rabies front. The distribution rate depends on the
topography, on the population density 
                                
                                Citiți documentul complet
                                
                            

Caracteristicilor produsului

                                ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
1
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Rabitec oral suspension for foxes and raccoon dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 dose (1.7 ml) contains:
ACTIVE SUBSTANCE:
Attenuated live rabies vaccine virus, strain SPBN GASGAS:
10
6.8
FFU* - 10
8.1
FFU*
(* Focus Forming Units)
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral suspension.
The suspension has a yellow colour in a frozen state and a reddish
colour in the liquid state. The baits
are rectangular, brownish coloured and have an intensive smell.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Foxes, raccoon dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the active immunization of foxes and raccoon dogs against rabies
to prevent infection and
mortality.
Duration of immunity: at least 12 months.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals:
Vaccine baits are not intended for vaccination of domestic animals.
Gastrointestinal signs (potentially due to the indigestible blister
material) have been reported in dogs
following accidental ingestion of the bait.
2
Special precautions to be taken by the person administering the
veterinary medicinal product to
animals:
Handle the baits with care. It is recommended to wear disposable
rubber gloves when handling and
distributing baits. In case of contact of the vaccine fluid,
immediately remove it by thoroughly rinsing
with water and soap. Seek medical advice immediately and show the
package leaflet or the label to the
physician.
Proposed first aid measures immediately after direct human exposure to
the vaccine fluid should
follow the recommendations of the WHO as outlined in the “WHO Guide
for Rabies Pre- and Post-
Exposure Prophylaxis (PEP) in Humans”.
Since this vaccine has been prepared with live, attenuated
microorganisms, appropriate measures
should be taken to prevent contamination of the handler a
                                
                                Citiți documentul complet
                                
                            

Documente în alte limbi

Prospect Prospect bulgară 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului bulgară 07-01-2021
Raport public de evaluare Raport public de evaluare bulgară 03-04-2020
Prospect Prospect spaniolă 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului spaniolă 07-01-2021
Raport public de evaluare Raport public de evaluare spaniolă 03-04-2020
Prospect Prospect cehă 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului cehă 07-01-2021
Raport public de evaluare Raport public de evaluare cehă 03-04-2020
Prospect Prospect daneză 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului daneză 07-01-2021
Raport public de evaluare Raport public de evaluare daneză 03-04-2020
Prospect Prospect germană 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului germană 07-01-2021
Raport public de evaluare Raport public de evaluare germană 03-04-2020
Prospect Prospect estoniană 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului estoniană 07-01-2021
Raport public de evaluare Raport public de evaluare estoniană 03-04-2020
Prospect Prospect greacă 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului greacă 07-01-2021
Raport public de evaluare Raport public de evaluare greacă 03-04-2020
Prospect Prospect franceză 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului franceză 07-01-2021
Raport public de evaluare Raport public de evaluare franceză 03-04-2020
Prospect Prospect italiană 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului italiană 07-01-2021
Raport public de evaluare Raport public de evaluare italiană 03-04-2020
Prospect Prospect letonă 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului letonă 07-01-2021
Raport public de evaluare Raport public de evaluare letonă 03-04-2020
Prospect Prospect lituaniană 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului lituaniană 07-01-2021
Raport public de evaluare Raport public de evaluare lituaniană 03-04-2020
Prospect Prospect maghiară 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului maghiară 07-01-2021
Raport public de evaluare Raport public de evaluare maghiară 03-04-2020
Prospect Prospect malteză 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului malteză 07-01-2021
Raport public de evaluare Raport public de evaluare malteză 03-04-2020
Prospect Prospect olandeză 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului olandeză 07-01-2021
Raport public de evaluare Raport public de evaluare olandeză 03-04-2020
Prospect Prospect poloneză 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului poloneză 07-01-2021
Raport public de evaluare Raport public de evaluare poloneză 03-04-2020
Prospect Prospect portugheză 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului portugheză 07-01-2021
Raport public de evaluare Raport public de evaluare portugheză 03-04-2020
Prospect Prospect română 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului română 07-01-2021
Raport public de evaluare Raport public de evaluare română 03-04-2020
Prospect Prospect slovacă 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului slovacă 07-01-2021
Raport public de evaluare Raport public de evaluare slovacă 03-04-2020
Prospect Prospect slovenă 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului slovenă 07-01-2021
Raport public de evaluare Raport public de evaluare slovenă 03-04-2020
Prospect Prospect finlandeză 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului finlandeză 07-01-2021
Raport public de evaluare Raport public de evaluare finlandeză 03-04-2020
Prospect Prospect suedeză 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului suedeză 07-01-2021
Raport public de evaluare Raport public de evaluare suedeză 03-04-2020
Prospect Prospect norvegiană 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului norvegiană 07-01-2021
Prospect Prospect islandeză 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului islandeză 07-01-2021
Prospect Prospect croată 07-01-2021
Caracteristicilor produsului Caracteristicilor produsului croată 07-01-2021
Raport public de evaluare Raport public de evaluare croată 03-04-2020

Vizualizați istoricul documentelor